/LFST

LifeStance Health Group Inc

LFST

$12.97USD↓-0.23%-0.03 today

MARKET CAP

5.0B

P/E (TTM)

324.3x

FWD P/E

—

DAY RANGE

$13 – $13

52W RANGE

$5

$13

AI Summary

Stalk

Sell NowMedium

Sell now into the marginal new‐high resistance area; the Bullish Exhaustion pattern combined with extreme overbought conditions and a Stage 3 distribution context suggest a high probability pullback or reversal, warranting bearish participation.

↑26% YoY revenue growth to $435M in Q2, net income rebounded to $24M.
↑Raised 2026 revenue guidance to $1.685–1.725B, implying ~20% growth.
↓Elevated volatility may cause large stock price swings and deter investors.

Full analysis →

Buying

6

institutions

Selling

7

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	36.35 M	389.29 M	+18.21 M	+237.0%	0.01%
MM Millennium Management LLC Q2 2026	BUY	3.61 M	38.63 M	+1.63 M	+207.2%	0.01%
WP Woodline Partners LP Q2 2026	SELL	2.07 M	22.15 M	+-1.56 M	-4.2%	0.07%
AC Aqr Capital Management LLC Q2 2026	BUY	1.25 M	13.35 M	+257.57 K	+111.9%	0.00%
RT Renaissance Technologies LLC Q2 2026	BUY	960.01 K	10.28 M	+159.51 K	+101.6%	0.01%
CA Citadel Advisors LLC Q2 2026	SELL	560.59 K	6.00 M	+-3.30 M	-75.6%	0.00%
JC Jpmorgan Chase & Co Q2 2026	SELL	157.96 K	1.73 M	+-54.00	+75.5%	0.00%
JH Janus Henderson Group Plc Q1 2026	BUY	189.00 K	1.20 M	+94.50 K	+80.7%	0.00%
MG Man Group Plc Q2 2026	SELL	110.16 K	1.18 M	+-54.35 K	+12.6%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	SELL	65.66 K	703.20 K	+-677.09 K	-85.1%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	SELL	48.69 K	521.42 K	+-4.31 K	+54.5%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	BUYNEW	3.05 K	32.67 K	+3.05 K	+0.0%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	SELL	0.00	0.00	+-391.15 K	-100.0%	0.00%